Oral bioavailability of curcumin: problems and advancements

Journal of Drug Targeting

Volumn 24, Issue 8, 2016, Pages 694-702

  Liu, Weidong ^a   Zhai, Yingjie ^b   Heng, Xueyuan ^a   Che, Feng Yuan ^a   Chen, Wenjun ^a   Sun, Dezhong ^a   Zhai, Guangxi ^b  

^a LINYI PEOPLE'S HOSPITAL   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Curcumin; liposomes; nanoparticles; oral bioavailability

Indexed keywords

CURCUMIN; DRUG METABOLITE; LIPOSOME; NANOCARRIER; PHOSPHOLIPID; POLYMER; POLYMERIC MICELLE; UNCLASSIFIED DRUG; BIOMATERIAL; DRUG CARRIER; NANOPARTICLE;

COMPLEX FORMATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG METABOLISM; DRUG SOLUBILITY; DRUG TRANSFORMATION; METABOLIC CLEARANCE; MICROEMULSION; NANOEMULSION; PRIORITY JOURNAL; REVIEW; ANIMAL; BIOAVAILABILITY; CHEMICAL STRUCTURE; CHEMISTRY; EMULSION; HUMAN; MICELLE; ORAL ABSORPTION; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANIMALS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL AVAILABILITY; CURCUMIN; DRUG CARRIERS; EMULSIONS; HUMANS; LIPOSOMES; MICELLES; MOLECULAR STRUCTURE; NANOPARTICLES; ORAL MUCOSAL ABSORPTION;

EID: 84961217782     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2016.1157883     Document Type: Review

References (82)

1. A.Alexander, A.Qureshi, L.Kumari Role of herbal bioactives as a potential bioavailability enhancer for active pharmaceutical ingredients. Fitoterapia 2014;97:1–14.
2. B.B.Aggarwal, C.Sundaram, N.Malani Curcumin: the Indian solid gold [M]//The molecular targets and therapeutic uses of curcumin in health and disease. New York: Springer; 2007:1–75.
3. M.Thiyagarajan, S.S.Sharma Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci 2004;74:969–85.
4. R.Motterlini, R.Foresti, R.Bassi Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 2000;28:1303–12.
5. A.Chen, J.Xu, A.C.Johnson Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene 2006;25:278–87.
6. S.Bhattacharyya, D.Mandal, G.S.Sen,. Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin. Cancer Res 2007;67:362–70.
7. S.Barthelemy, L.Vergnes, M.Moynier Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat. Res Virol 1998;149:43–52.
8. B.B.Aggarwal, K.B.Harikumar Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 2009;41:40–59.
9. K.Ono, K.Hasegawa, H.Naiki. Curcumin has potent anti-amyloidogenic effects for Alzheimer’s beta-amyloid fibrils in vitro. J Neurosci Res 2004;75:742–50.
10. S.Shishodia, G.Sethi, B.B.Aggarwal Curcumin: getting back to the roots. Ann N Y Acad Sci 2005;1056:206–17.
11. A.B.Kunnumakkara, P.Anand, B.B.Aggarwal Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 2008;269:199–225.
12. K.Y.Yang, L.C.Lin, T.Y.Tseng. Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. J Chromatogr B 2007;853:183–9.
13. M.H.Pan, T.M.Huang, J.K.Lin Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 1999;27:486–94.
14. C.D.Lao, M.T.Ruffin, D.Normolle Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 2006;6:10.
15. X.Cai, Z.Fang, J.Dou Bioavailability of quercetin: problems and promises. Curr Med Chem 2013;20:2572–82.
16. L.Zhang, W.Zhu, C.Yang A novel folate-modified self-microemulsifying drug delivery system of curcumin for colon targeting. Int J Nanomed 2012;7:151.
17. H.H.Tønnesen, J.Karlsen Studies on curcumin and curcuminoids. Zeitschrift für Lebensmittel-Untersuchung und Forschung 1985;180:402–4.
18. L.Palanikumar, N.Panneerselvam Curcumin: a putative chemopreventive agent. J Life Sci 2009;3:47–53.
19. S.I.Hoehle, E.Pfeiffer, A.M.Solyom,. Metabolism of curcuminoids in tissue slices and subcellular fractions from rat liver. J Agric Food Chem 2006;54:756–64.
20. C.Ireson, S.Orr, D.J.L.Jones Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res 2001;61:1058–64.
21. C.R.Ireson, D.J.L.Jones, S.Orr Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev 2002;11:105–11.
22. T.Kurita, Y.Makino Novel curcumin oral delivery systems. Anticancer Res 2013;33:2807–21.
23. L.Helson Curcumin (diferuloylmethane) delivery methods: a review. Biofactors 2013;39:21–6.
24. U.Citernesi, M.Sciacchitano Phospholipid/active ingredient complexes. Cosmetics Toiletries 1995;110:57–68.
25. P.M.Kidd Phosphatidylcholine, a superior protectant against liver damage. Altern Med Rev 1996;1:258–74.
26. N.Barzaghi, F.Crema, G.Gatti Pharmacokinetic studies on IdB 1016, a silybin-phosphatidylcholine complex, in healthy human subjects. Eur J Drug Metab Pharmacokinet 1990;15:333–8.
27. G.Buzzelli, S.Moscarella, A.Giusti A pilot study on the liver protective effect of silybin-phosphatidylcholine complex (IdB1016) in chronic active hepatitis. Int J Clin Pharmacol 1993;31:456–60.
28. A.Liu, H.Lou, L.Zhao Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin. J Pharm Biomed Anal 2006;40:720–7.
29. K.Maiti, K.Mukherjee, A.Gantait,. Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 2007;330:155–63.
30. N.K.Gupta, V.K.Dixit Bioavailability enhancement of curcumin by complexation with phosphatidyl choline. J Pharm Sci 2011;100:1987–95.
31. M.J.Lawrence, G.D.Rees Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 2000;45:89–121.
32. R.Strey Microemulsion microstructure and interfacial curvature. Colloid Polym Sci 1994;272:1005–19.
33. F.Kesisoglou, S.Panmai, Y.Wu Application of nanoparticles in oral delivery of immediate release formulations. Curr Nanosci 2007;3:183–90.
34. S.P.Moulik, B.K.Paul Structure, dynamics and transport properties of microemulsions. Adv Colloid Interface Sci 1998;78:99–195.
35. Y.M.Yin, F.D.Cui, C.F.Mu Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation. J Control Release 2009;140:86–94.
36. G.R.Neslihan, S.Benita Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 2004;58:173–82.
37. X.Wu, J.Xu, X.Huang Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability. Drug Dev Ind Pharm 2011;37:15–23.
38. A.S.Narang, D.Delmarre, D.Gao Stable drug encapsulation in micelles and microemulsions. Int J Pharm 2007;345:9–25.
39. K.Ahmed, Y.Li, D.V.McClements,. Nanoemulsion- and emulsion-based delivery systems for curcumin: encapsulation and release properties. Food Chem 2012;132:799–807.
40. X.Wang, Y.Jiang, Y.W.Wang Enhancing anti-inflammation activity of curcumin through O/W nanoemulsions. Food Chem 2008;108:419–24.
41. D.J.Jang, S.T.Kim, E.Oh Enhanced oral bioavailability and antiasthmatic efficacy of curcumin using redispersible dry emulsion. Biomed Mater Eng 2014;24:917–30.
42. M.C.Bergonzi, R.Hamdouch, F.Mazzacuva Optimization, characterization and in vitro evaluation of curcumin microemulsions. LWT-Food Sci Technol 2014;59:148–55.
43. J.Cui, B.Yu, Y.Zhao Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm 2009;371:148–55.
44. S.Setthacheewakul, S.Mahattanadul, N.Phadoongsombut Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats. Eur J Pharm Biopharm 2010;76:475–85.
45. H.Yu, Q.Huang Improving the oral bioavailability of curcumin using novel organogel-based nanoemulsions. J Agric Food Chem 2012;60:5373–9.
46. H.Yu, K.Shi, D.Liu Development of a food-grade organogel with high bioaccessibility and loading of curcuminoids. Food Chem 2012;131:48–54.
47. L.Li, F.S.Braiteh, R.Kurzrock. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 2005;104:1322–31.
48. M.Kreilgaard Influence of microemulsions on cutaneous drug delivery. Adv Drug Deliv Rev 2002;54:S77–98.
49. H.Chen, J.Wu, M.Sun N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin. J Liposome Res 2012;22:100–9.
50. M.Takahashi, S.Uechi, K.Takara Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin. J Agric Food Chem 2009;57:9141–6.
51. V.Kakkar, S.Singh, D.Singla Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Mol Nutr Food Res 2011;55:495–503.
52. J.Cuomo, G.Appendino, A.S.Dern Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J Nat Prod 2011;74:664–9.
53. C.Mohanty, M.Das, S.K.Sahoo Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin. Expert Opin Drug Deliv 2012;9:1347–64.
54. N.Hussain, V.Jaitley, A.T.Florence Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv Drug Deliv Rev 2001;50:107–42.
55. H.Yuan, J.Chen, Y.Z.Du Studies on oral absorption of stearic acid SLN by a novel fluorometric method. Colloids Surf B Biointerfaces 2007;58:157–64.
56. S.J.Lim, M.K.Lee, C.K.Kim Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders. J Control Release 2004;100:53–61.
57. W.H.Lee, C.Y.Loo, P.M.Young Recent advances in curcumin nanoformulation for cancer therapy. Expert Opin Drug Deliv 2014;11:1183–201.
58. T.M.Allen Liposomal drug formulations. Drugs 1998;56:747–56.
59. C.Yang, Z.X.Fu Liposomal delivery and polyethylene glycol-liposomal oxaliplatin for the treatment of colorectal cancer (Review). Biomed Rep 2014;2:335–9.
60. S.Bégu, A.A.Pouëssel, D.A.Lerner Liposil, a promising composite material for drug storage and release. J Control Release 2007;118:1–6.
61. C.Li, Y.Zhang, T.Su Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin. Int J Nanomed 2012;7:5995–6002.
62. H.Cabral, K.Kataoka Progress of drug-loaded polymeric micelles into clinical studies. J Control Release 2014;190:465–76.
63. Y.Lu, K.Park Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. Int J Pharm 2013;453:198–214.
64. B.Reddy, H.K.S.Yadav, D.K.Nagesha. Polymeric micelles as novel carriers for poorly soluble drugs – a review. J Nanosci Nanotechnol 2015;15:4009–18.
65. A.Maitra, G.Feldmann, S.Bisht Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles: U.S. Patent 8,715,741[P]. 2014-5-6.
66. G.Gaucher, P.Satturwar, M.C.Jones Polymeric micelles for oral drug delivery. Eur J Pharm Biopharm 2010;76:147–58.
67. K.Letchford, R.Liggins, H.Burt Solubilization of hydrophobic drugs by methoxy poly (ethylene glycol)-block-polycaprolactone diblock copolymer micelles: theoretical and experimental data and correlations. J Pharm Sci 2008;97:1179–90.
68. L.Zhao, J.Du, Y.Duan,. Curcumin loaded mixed micelles composed of pluronic P123 and F68: preparation, optimization and in vitro characterization. Colloids Surf B Biointerfaces 2012;97:101–8.
69. Z.Ma, A.Shayeganpour, D.R.Brocks,. High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin. Biomed Chromatogr 2007;21:546–52.
70. C.Schiborr, A.Kocher, D.Behnam The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Mol Nutr Food Res 2014;58:516–27.
71. A.L.Cheng, C.H.Hsu, J.K.Lin,. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001;21:2895–900.
72. I.Bala, V.Bhardwaj, S.Hariharan Sustained release nanoparticulate formulation containing antioxidant-ellagic acid as potential prophylaxis system for oral administration. J Drug Target 2006;14:27–34.
73. H.Ji, J.Tang, M.Li Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin. Drug Deliv 2016;23:459–70.
74. P.Ramalingam, Y.T.Ko Enhanced oral delivery of curcumin from N-trimethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluations. Pharm Res 2015;32:389–402.
75. J.Shaikh, D.D.Ankola, V.Beniwal Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 2009;37:223–30.
76. X.Xie, Q.Tao, Y.Zou PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms. J Agric Food Chem 2011;59:9280–9.
77. T.Bansal, G.Mishra, M.Jaggi Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats. Eur J Pharm Sci 2009;36:580–90.
78. G.M.Holder, J.L.Plummer, A.J.Ryan The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat. Xenobiotica 1978;8:761–8.
79. G.Shoba, D.Joy, T.Joseph Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998;64:353–6.
80. P.Anand, A.B.Kunnumakkara, R.A.Newman Bioavailability of curcumin: problems and promises. Mol Pharm 2007;4:807–18.
81. A.E.Grill, B.Koniar, J.Panyam Co-delivery of natural metabolic inhibitors in a self-microemulsifying drug delivery system for improved oral bioavailability of curcumin. Drug Deliv Trans Res 2014;4:344–52.
82. M.Salem, S.Rohani, E.R.Gillies Curcumin, a promising anti-cancer therapeutic: a review of its chemical properties, bioactivity and approaches to cancer cell delivery. RSC Adv 2014;4:10815–29.